Overview
- In a New York Times interview, President Donald Trump said he has never used GLP-1 drugs such as Ozempic or Wegovy and added, "I probably should."
- The administration announced a deal in November 2025 to cut prices for popular prescription medicines, including GLP-1 treatments, with a target cost near $149 per month.
- At an Oval Office event promoting the pricing plan, Trump asked senior aides if they were using the medications, and Commerce Secretary Howard Lutnick replied, "Not yet."
- Trump joked that communications director Steven Cheung was taking a GLP-1 drug, a claim that has not been confirmed publicly.
- The White House physician reported Trump’s weight as 224 pounds in April 2025, down from 244 pounds in 2020, placing him in the overweight category.